Our research covers a range of medicinal chemistry and chemical biology areas focused on malaria, TB and filariasis. Our approach involves a broad range of synthesis approaches, modeling and biological testing. Much of our work is carried with collaborators including Professor Kevin Park (MRC CDSS, Institute of Translational Medicine, University of Liverpool), as well as partnerships with Liverpool School of Tropical Medicine (Professors Ward, Biagini and Taylor) and industrial partner groups including Astra Zeneca, Eisai (Boston, USA) and GSK (Tres Cantos, Madrid, Spain). More recently we have also initiated medicinal chemistry programmes in neuropathic pain and pancreatitis.